Sugammadex and neuromuscular reversal: special focus on neonatal and infant populations.
Sign Up to like & getrecommendations! Published in 2020 at "Current Opinion in Anaesthesiology"
DOI: 10.1097/aco.0000000000000847
Abstract: PURPOSE OF REVIEW Sugammadex is a novel selective muscle relaxant binding agent capable of reversing deep neuromuscular blockade from rocuronium or vecuronium. It has not been approved for use in children by the US FDA… read more here.
Keywords: neuromuscular reversal; sugammadex; focus neonatal; reversal special ... See more keywords